Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal pethidine versus bupivacaine for hemodynamic stability in hip surgery
IRCT20180603039966N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of pethidine and bupivacaine in hip fracture and femoral fracture (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoints: Heart rate, Mean arterial pressure and 2 more. Started Jul 2018; status: completed.
02
Drugs
pethidinebupivacaine
03
Conditions
hip fracturefemoral fracture
Beyond the preview
Go deeper on IRCT20180603039966N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180603039966N1.